Sperling Prostate Center

Month: May 2016

Changing Trends in PSA Screening

Before the U.S. Preventive Services Task Force Panel’s 2012 recommendation against broad PSA screening, the blood test was commonly offered to men age 50 and over (45 if you had known risk factors). The Panel’s directive started a push in the opposite direction, encouraging doctors to discuss with each patient the merits and downsides of keep reading

Great News About Multiparametric MRI

It is always gratifying for a doctor when something he or she wholeheartedly believes in gets affirmed by published research. For me, this is the case with a new Italian study, “The Roles of Multiparametric MRI, PCA3, and PHI: Which Is The Best Predictor of Prostate Cancer After a Negative Biopsy?”[i] The authors recognize the keep reading

Exercise Related to Treatment Success

A study presented in 2014 at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research reported a surprising relationship between vigorous exercise and the shape of blood vessels found in prostate cancer tumors. Men who walked faster prior to a diagnosis of prostate cancer were found to have more regularly shaped blood vessels keep reading

Prostate Cancer and Medicare Fraud

It’s tempting to become cynical about medicine when one hears reports of Medicare abuse or violations of Federal laws. These stories are especially rankling when greed appears to be the motive, and the victims are cancer patients. A few years ago, journalist Peter Waldman, writing for Bloomberg Business, assembled several anecdotes into a disturbing article keep reading
WordPress Image Lightbox